Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“Early on, I read about some cancer patients who get hung up on ‘why me?’ My response was ‘why not me?’”
Being obese was linked to a fourfold increase in pancreatic cancer risk.
Advocates, oncologists and researchers share findings, resources and reasons for hope at third annual NW Mets Conference.
Don’t delay! But be aware of these changes to the 2019 Affordable Care Act marketplace.
This month, we raise awareness about what lung cancer is, how to lower your risk, and how important screening is for those at high risk.
Half of people with worse liver function responded well to immunotherapy.
Oncologists warn: They can’t.
After his first bout with acute lymphoblastic leukemia, Connor McMahon wanted to give other children hope.
We’re interested in assessing how diet affects health—but in the context of the what, where, when, why, and how we eat.
Physicians recognize that ovarian cancer isn’t a single disease but a group of related disorders with distinct genetic and cellular features
Results don’t support screening healthy people for vitamin D deficiency.
Whether such recurrence is less likely after interferon treatment remains the source of some controversy in the hep C research community.
Scientists are preparing to bring DNA-editing tools to the clinic.
Liver fat may be a driver of increased cancer risk associated with obesity.
Over the last five years, FDA has authorized more than 9,000 applications through the expanded access program.
A second immunotherapy option is now available for hepatocellular carcinoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.